BJU Int:医院手术量与膀胱癌根治术治疗后的死亡率有关

2021-02-24 AlexYang MedSci原创

最近,有研究人员通过评估医院手术量(HV)与术后死亡率之间的关系,促进了关于医院应进行的根治性膀胱切除术(RCs)最低手术量的辩论。

最近,有研究人员通过评估医院手术量(HV)与术后死亡率之间的关系,促进了关于医院应进行的根治性膀胱切除术(RCs)最低手术量的辩论。

研究人员在2008年1月1日至2018年12月31日期间对因膀胱癌接受RC的患者进行回顾性鉴定。为了创建一个日历年独立的测量,研究人员通过统计手术前12个月在同一医院进行的RC,计算出每位患者RC的HV。通过logistic回归评估了HV与30天和90天死亡率的关系。结果表明,9287名RC治疗患者的HV中位数(四分位数范围;范围)为19(12-27;1-75)。在所有纳入的患者中,分别有208名(2.2%)和518名(5.6%)在RC后30天和90天内死亡。调整了年龄、TNM阶段和新辅助治疗后,术后死亡率在HV为0至HV为25 RC之间略有增加,从HV为30起稳步下降。手术量最高的术后死亡风险最低。

最后,研究人员指出,他们的研究基于一个全国性大型人群队列的高质量数据,表明每年将RC数量标准提高到30个RC以上可以进一步降低术后死亡率。基于这些结果,欧洲泌尿外科协会指南小组最近推荐的每年20个RC的数量标准可能因此会被重新考虑。

原始出处:

Anke Richters , Theodora M Ripping , Lambertus A Kiemeney et al. Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer. BJU Int. Jan 2021

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-03-04 1581fad5efm

    这都行。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-26 T2DM终结者

    为啥还和手术量有关...?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-26 redcrab
  5. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-26 redcrab
  6. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-26 jeanqiuqiu
  7. [GetPortalCommentsPageByObjectIdResponse(id=945400, encodeId=688c945400f6, content=这都行。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210111/616dbbab55eb4932bdf19a58a012e1c4/b9af285344e4473e9f6f9c6ac8935960.jpg, createdBy=844f2121780, createdName=1581fad5efm, createdTime=Thu Mar 04 11:45:18 CST 2021, time=2021-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943845, encodeId=248d9438450f, content=为啥还和手术量有关...? , beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210226/f23705539a22465dad49b185641246f4/269e005bb68348558ceb01a4a8056073.jpg, createdBy=a54d5390453, createdName=T2DM终结者, createdTime=Fri Feb 26 22:57:28 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399748, encodeId=3e651399e4820, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561797, encodeId=e6ff1561e97a1, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567806, encodeId=9dd7156e8061c, content=<a href='/topic/show?id=2fcf545116c' target=_blank style='color:#2F92EE;'>#手术量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54511, encryptionId=2fcf545116c, topicName=手术量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2215204545, createdName=redcrab, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586207, encodeId=16d7158620ec8, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Fri Feb 26 11:33:34 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040013, encodeId=dd1110400136f, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Wed Feb 24 23:33:34 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-24 留走人康

    膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效

    0

相关资讯

Eur Urol:膀胱癌患者的机器人辅助根治性膀胱切除术与开放性根治性膀胱切除术的比较

膀胱癌患者中进行根治性膀胱切除术加盆腔淋巴结切除术(PLND)和尿液转流术具有高风险并发症。尽管开放性根治性膀胱切除术(ORC)是标准的治疗方法,且缺乏比较两种技术有效性的高质量证据,但机器人辅助根治

Oncogene:KNSTRN通过激活膀胱癌中的AKT来促进肿瘤的发生和吉西他滨的耐药性

KNSTRN是有丝分裂纺锤体的一个组成部分,在肿瘤发生中很少有研究。AKT通过调控各种底物的磷酸化,在肿瘤发生中起着重要作用。AKT的激活是由PTEN和PIP3调节的。

Nat Commun:血浆ctDNA可作为肿瘤组织的代用品来实现转移性膀胱癌的临床基因组分层

分子分层可以改善晚期癌症的治疗,但需要相关的肿瘤样本。转移性尿道癌(mUC)将受益鉴于最近治疗方案的扩展及其高基因组异质性。

ASCO GU 2021: IL-15RαFc超激动剂N-803在对BCG反应的NMIBC膀胱癌原位癌患者中的研究(QUILT 3.032试验)

2019年,美国FDA授予ImmunityBio公司IL-15超级激动剂N-803突破性疗法认定,用于与卡介苗(BCG)联合治疗此前对BCG反应不佳的非肌层浸润性原位膀胱癌(CIS)患者。Immuni

JCI:尿液DNA甲基化测定可对膀胱癌进行早期检测和复发预测

膀胱癌(BCa)是泌尿系统最常见的恶性肿瘤,全世界每年估计约有549,393例新发病例和约199,922例死亡病例。

得了膀胱癌,坚决不全切?新手术方案让他恢复自主排尿及性功能

术后三个月的他就已回到工作岗位,日常生活业回归正常轨迹。回首这段往事,陈先生至今仍记忆犹新。